Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments

Hepatoid adenocarcinoma of the stomach (HAS) is a rare malignant tumor, accounting for only 0.17–15% of gastric cancers. Patients are often diagnosed at an advanced disease stage, and their symptoms are similar to conventional gastric cancer (CGC) without specific clinical manifestation. Morphologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Ruolan, Zhou, Yuwen, Wang, Yuqing, Yuan, Jiaming, Ma, Xuelei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071951/
https://www.ncbi.nlm.nih.gov/pubmed/33912455
http://dx.doi.org/10.3389/fonc.2021.633916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071951/
https://www.ncbi.nlm.nih.gov/pubmed/33912455
http://dx.doi.org/10.3389/fonc.2021.633916

Ejemplares similares